Next Article in Journal
White Shrimp Litopenaeus vannamei That Have Received Gracilaria tenuistipitata Extract Show Early Recovery of Immune Parameters after Ammonia Stressing
Previous Article in Journal
Drimane Sesquiterpene-Conjugated Amino Acids from a Marine Isolate of the Fungus Talaromyces minioluteus (Penicillium Minioluteum)
Article Menu

Export Article

Open AccessArticle
Mar. Drugs 2015, 13(6), 3581-3605; doi:10.3390/md13063581

Antibiofilm Activity of the Brown Alga Halidrys siliquosa against Clinically Relevant Human Pathogens

1
School of Pharmacy, Queen's University Belfast, 97 Lisburn Road, BT9 7BL Belfast, UK
2
School of Biological Sciences, Medical Biology Center, 97 Lisburn Road, BT9 7BL Belfast, UK
*
Author to whom correspondence should be addressed.
Academic Editor: Alejandro M. Mayer
Received: 19 January 2015 / Revised: 27 May 2015 / Accepted: 27 May 2015 / Published: 5 June 2015
View Full-Text   |   Download PDF [2404 KB, uploaded 5 June 2015]   |  

Abstract

The marine brown alga Halidrys siliquosa is known to produce compounds with antifouling activity against several marine bacteria. The aim of this study was to evaluate the antimicrobial and antibiofilm activity of organic extracts obtained from the marine brown alga H. siliquosa against a focused panel of clinically relevant human pathogens commonly associated with biofilm-related infections. The partially fractionated methanolic extract obtained from H. siliquosa collected along the shores of Co. Donegal; Ireland; displayed antimicrobial activity against bacteria of the genus Staphylococcus; Streptococcus; Enterococcus; Pseudomonas; Stenotrophomonas; and Chromobacterium with MIC and MBC values ranging from 0.0391 to 5 mg/mL. Biofilms of S. aureus MRSA were found to be susceptible to the algal methanolic extract with MBEC values ranging from 1.25 mg/mL to 5 mg/mL respectively. Confocal laser scanning microscopy using LIVE/DEAD staining confirmed the antimicrobial nature of the antibiofilm activity observed using the MBEC assay. A bioassay-guided fractionation method was developed yielding 10 active fractions from which to perform purification and structural elucidation of clinically-relevant antibiofilm compounds. View Full-Text
Keywords: Halidrys siliquosa; antimicrobial; antibiofilm; clinical strains; biodiscovery; extraction Halidrys siliquosa; antimicrobial; antibiofilm; clinical strains; biodiscovery; extraction
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Busetti, A.; Thompson, T.P.; Tegazzini, D.; Megaw, J.; Maggs, C.A.; Gilmore, B.F. Antibiofilm Activity of the Brown Alga Halidrys siliquosa against Clinically Relevant Human Pathogens. Mar. Drugs 2015, 13, 3581-3605.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top